Form 4 for TNON Tenon Medical, Inc.
Accepted 2026-09-10 16:01:19 ET · period of report 2026-09-08 · accession 0001213900-26-098774 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-10 16:01 | 2026-09-08 | TNON | Williamson Kevin | CFO | M - OptEx | $0.00 | +30 | 2,591 | +1% | $0 |
| D | 2026-09-10 16:01 | 2026-09-09 | TNON | Williamson Kevin | CFO | F - Tax | $3.45 | -11 | 2,580 | -0.4% | -$37.95 |
| D | 2026-09-10 16:01 | 2026-09-08 | TNON | Williamson Kevin | CFO | M - OptEx | $0.00 | -30 | 60 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-08 | M | A | 30 | $0.00 | 2,591 | D | — | — | (F1) Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. |
| 2 | Common | Common Stock | 2026-09-09 | F | D | 11 | $3.45 | 2,580 | D | — | — | (F3) These shares were sold to pay tax liability associated with the vesting of RSUs. |
| 3 | Derivative | Restricted Stock Units | 2026-09-08 | M | D | 30 | $0.00 | 60 | D | — · — to — | 30 Common Stock | (F1) Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. (F2) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F1) Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. (F1) Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. |